Pharmaceutical Menotropin Research Overview
Merional 150 IU is a pharmaceutical menotropin preparation containing follicle-stimulating hormone (FSH) and luteinising hormone (LH) in a 1:1 ratio. Manufactured by IBSA, this gonadotropin formulation serves as a reference standard for reproductive endocrinology research examining hormone receptor binding kinetics and intracellular signalling cascades. Research laboratories at Stroid UK Shop investigate menotropin preparations to study gonadotropin receptor pharmacology and reproductive hormone mechanisms in controlled experimental conditions.
Laboratory Research Applications
Research teams evaluate Merional’s FSH and LH components for their distinct receptor binding profiles and downstream signalling pathway activation. Studies examine gonadotropin receptor expression patterns in various cell lines and analyse cAMP-dependent protein kinase activation following hormone binding. Investigators compare menotropin preparations against recombinant hormone standards to characterise bioactivity differences in reproductive research models. The pharmaceutical formulation enables standardised research protocols examining hormone-receptor interactions. Scientists studying menotropin compounds often compare natural-derived preparations with synthetic alternatives for receptor binding affinity studies.
Technical Research Specifications
| Parameter | Specification |
|---|---|
| Active Components | FSH 75 IU, LH 75 IU |
| Manufacturer | IBSA Pharmaceuticals |
| Formulation | Lyophilised powder |
| Research Use | Gonadotropin receptor studies |
| Storage | 2-8°C, protect from light |
| Reconstitution | Sterile water for injection |
Comparative studies with SARM compounds and research peptides help investigators understand different hormone receptor mechanisms and their cellular responses in reproductive biology research.
Research Compliance Information
Merional 150 IU is supplied strictly for in-vitro laboratory research applications investigating gonadotropin receptor pharmacology and reproductive hormone mechanisms. This pharmaceutical preparation is not intended for human consumption, clinical use, or therapeutic applications. Research institutions must maintain appropriate documentation and follow established protocols for handling pharmaceutical research materials. Investigators should verify product specifications with the supplier and ensure compliance with institutional research guidelines when conducting gonadotropin studies.
